Skip to content
The Science Behind Lung Cancer Screening episode artwork

Sep 25, 2026 43 min

The Science Behind Lung Cancer Screening

from UVA Data Points Hosted by UVA School of Data Science

Lung cancer remains one of the leading causes of cancer death, in part because it is often detected too late. But deciding who should be screened is more complicated than it might seem. In this episode of UVA Data Points, Jeffrey Blume, interim Stephenson Dean of the University of Virginia School of Data Science, and Melinda Aldrich, a cancer epidemiologist at Vanderbilt University, explore how data science is helping researchers better understand lung cancer risk and improve screening decisions. They discuss the role of smoking history, genetics, and environmental exposures; the risks and benefits of screening; and how emerging tools such as AI, medical imaging, biomarkers, and wearable technology could shape the future of early detection. The conversation also examines a fundamental data science challenge: How do you bring together complex and imperfect data to identify the people most likely to benefit from screening, while avoiding unnecessary tests and their potential harms? Chapters (00:00:02) - Introduction: Who Should Be Screened for Lung Cancer? (00:01:16) - Meet the Experts: Jeffrey Blume and Melinda Aldrich (00:03:51) - Why Lung Cancer Screening Is So Complicated (00:06:51) - The Risks and Benefits of Lung Cancer Screening (00:08:25) - How Data Science Helps Predict Lung Cancer Risk (00:10:34) - Environmental and Occupational Exposures (00:12:33) - Geography, Radon, and Local Risk Factors (00:14:43) - Funding, Grants, and Building Research Teams (00:16:47) - Genetics and Nicotine Metabolism Differences (00:19:49) - Modeling Individual Risk Factors (00:22:25) - Balancing Benefits and Harms of Screening (00:24:39) - Genetic Markers: BRCA Comparison and Biomarkers (00:27:44) - Blood Tests and Imaging Integration (00:28:53) - Imaging Data, AI, and Prediction Models (00:33:19) - International Screening Guidelines Comparison (00:34:40) - Future Directions: Wearables and New Data Sources (00:36:52) - Machine Learning Challenges and Attribution of Risk (00:41:41) - Closing Thoughts and Personal Impact (00:43:10) - Outro and Podcast Information

Episode details come from the podcast's RSS feed.

Embed this episode

Lung cancer remains one of the leading causes of cancer death, in part because it is often detected too late. But deciding who should be screened is more complicated than it might seem. In this episode of UVA Data Points, Jeffrey Blume, interim Stephenson Dean of the University of Virginia School of Data Science, and Melinda Aldrich, a cancer epidemiologist at Vanderbilt University, explore how data science is helping researchers better understand lung cancer risk and improve screening decisions. They discuss the role of smoking history, genetics, and environmental exposures; the risks and benefits of screening; and how emerging tools such as AI, medical imaging, biomarkers, and wearable technology could shape the future of early detection. The conversation also examines a fundamental data science challenge: How do you bring together complex and imperfect data to identify the people most likely to benefit from screening, while avoiding unnecessary tests and their potential harms?

Ready to play

The Science Behind Lung Cancer Screening

0:00 43:34

Chapters

  1. 0:02 Introduction: Who Should Be Screened for Lung Cancer?
  2. 1:16 Meet the Experts: Jeffrey Blume and Melinda Aldrich
  3. 3:51 Why Lung Cancer Screening Is So Complicated
  4. 6:51 The Risks and Benefits of Lung Cancer Screening
  5. 8:25 How Data Science Helps Predict Lung Cancer Risk
  6. 10:34 Environmental and Occupational Exposures
  7. 12:33 Geography, Radon, and Local Risk Factors
  8. 14:43 Funding, Grants, and Building Research Teams
  9. 16:47 Genetics and Nicotine Metabolism Differences
  10. 19:49 Modeling Individual Risk Factors
  11. 22:25 Balancing Benefits and Harms of Screening
  12. 24:39 Genetic Markers: BRCA Comparison and Biomarkers
  13. 27:44 Blood Tests and Imaging Integration
  14. 28:53 Imaging Data, AI, and Prediction Models
  15. 33:19 International Screening Guidelines Comparison
  16. 34:40 Future Directions: Wearables and New Data Sources
  17. 36:52 Machine Learning Challenges and Attribution of Risk
  18. 41:41 Closing Thoughts and Personal Impact
  19. 43:10 Outro and Podcast Information

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of UVA Data Points?

This episode is 43 minutes long.

When was this UVA Data Points episode published?

This episode was published on September 25, 2026.

Can I download this UVA Data Points episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.